Elizabeth Yeu Lin, Director at Tarsus Pharmaceuticals, Inc. (TARS), bought 19,012 shares at $16.80 ($319K) on 2023-08-15, disclosed to the SEC on 2023-08-17.
Open-market purchase of $319k TARS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.80 | 9,506 | $160K | 50.0% |
| 2 | $16.80 | 9,506 | $160K | 50.0% |
| Total | $16.80 avg | 19,012 | $319K | 100% |
| Filing → |
| TARS | SELL | 2026-03-19 | $78K | — | Filing → |
| TARS | SELL | 2025-12-17 | $165K | — | Filing → |
| TARS | SELL | 2025-06-17 | $41K | — | Filing → |